Hills Bank & Trust Co. Has $2.90 Million Holdings in CVS Health Corp (NYSE:CVS)

Hills Bank & Trust Co. grew its holdings in CVS Health Corp (NYSE:CVS) by 1.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 46,006 shares of the pharmacy operator’s stock after purchasing an additional 479 shares during the period. Hills Bank & Trust Co.’s holdings in CVS Health were worth $2,901,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of CVS. First Citizens Bank & Trust Co. raised its position in shares of CVS Health by 11.3% during the third quarter. First Citizens Bank & Trust Co. now owns 32,484 shares of the pharmacy operator’s stock valued at $2,048,000 after buying an additional 3,306 shares during the last quarter. Regent Investment Management LLC grew its stake in shares of CVS Health by 9.3% in the 3rd quarter. Regent Investment Management LLC now owns 76,404 shares of the pharmacy operator’s stock valued at $4,819,000 after purchasing an additional 6,475 shares during the last quarter. NEXT Financial Group Inc grew its stake in shares of CVS Health by 33.4% in the 3rd quarter. NEXT Financial Group Inc now owns 15,242 shares of the pharmacy operator’s stock valued at $962,000 after purchasing an additional 3,817 shares during the last quarter. LexAurum Advisors LLC purchased a new position in shares of CVS Health in the 3rd quarter valued at approximately $221,000. Finally, Wedbush Securities Inc. grew its stake in shares of CVS Health by 29.5% in the 3rd quarter. Wedbush Securities Inc. now owns 53,910 shares of the pharmacy operator’s stock valued at $3,400,000 after purchasing an additional 12,292 shares during the last quarter. 76.17% of the stock is currently owned by institutional investors.

Several research analysts have weighed in on CVS shares. Barclays lifted their target price on CVS Health from $75.00 to $79.00 and gave the company an “overweight” rating in a research note on Thursday. Mizuho lifted their price target on CVS Health from $71.00 to $82.00 and gave the company a “buy” rating in a research note on Friday. Citigroup lifted their price target on CVS Health from $72.00 to $83.00 and gave the company a “buy” rating in a research note on Thursday. They noted that the move was a valuation call. UBS Group restated a “buy” rating and issued a $78.00 price target on shares of CVS Health in a research note on Thursday. Finally, SunTrust Banks lifted their price target on CVS Health to $85.00 and gave the company a “buy” rating in a research note on Thursday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $77.59.

In other CVS Health news, EVP Joshua Matthew Flum sold 17,703 shares of the company’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $63.00, for a total transaction of $1,115,289.00. Following the completion of the sale, the executive vice president now owns 36,163 shares in the company, valued at approximately $2,278,269. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Eva C. Boratto sold 8,130 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $65.00, for a total transaction of $528,450.00. Following the sale, the chief financial officer now owns 55,273 shares of the company’s stock, valued at approximately $3,592,745. The disclosure for this sale can be found here. Insiders have sold a total of 49,437 shares of company stock valued at $3,248,811 in the last quarter. Corporate insiders own 0.53% of the company’s stock.

CVS stock traded up $0.69 during trading on Friday, hitting $72.47. The company had a trading volume of 9,079,719 shares, compared to its average volume of 6,966,567. The company has a quick ratio of 0.64, a current ratio of 0.95 and a debt-to-equity ratio of 1.39. The firm has a 50-day moving average price of $64.66 and a 200-day moving average price of $58.54. CVS Health Corp has a 12 month low of $51.72 and a 12 month high of $82.15. The stock has a market cap of $87.55 billion, a price-to-earnings ratio of 10.24, a PEG ratio of 1.46 and a beta of 0.86.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.07. The firm had revenue of $64.81 billion during the quarter, compared to analysts’ expectations of $62.99 billion. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. CVS Health’s revenue was up 36.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.73 EPS. Equities analysts expect that CVS Health Corp will post 6.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, November 4th. Shareholders of record on Thursday, October 24th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.76%. The ex-dividend date of this dividend was Wednesday, October 23rd. CVS Health’s payout ratio is 28.25%.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Featured Article: Blockchain

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.